Alan E Smith has an estimated net worth of $27.7 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, and Candel Therapeutics, Inc..
2003 was Alan E Smith's most active year for acquiring shares with 26 total transactions. Alan E Smith's most active month to acquire stocks was the month of May. 2003 was Alan E Smith's most active year for disposing of shares, totalling 36 transactions. Alan E Smith's most active month to dispose stocks was the month of May. 2008 saw Alan E Smith paying a total of $3,428,679.58 for 185,980 shares, this is the most they've acquired in one year. In 2008 Alan E Smith cashed out on 252,619 shares for a total of $10,452,096.07, their largest year based on trade value.